A Ring-Augmented Roux-en-Y Gastric Bypass with MiniMizer Ring is Effective and Safe in Patients with a BMI >50 kg/m2
- PMID: 40569360
- PMCID: PMC12380931
- DOI: 10.1007/s11695-025-07988-1
A Ring-Augmented Roux-en-Y Gastric Bypass with MiniMizer Ring is Effective and Safe in Patients with a BMI >50 kg/m2
Abstract
Background: The Roux-en-Y gastric bypass (RYGB) is regarded as one of the most effective treatments for obesity. The ring-augmented RYGB (raRYGB), has demonstrated superior long-term weight loss outcomes and better weight maintenance compared to the standard RYGB. There is no agreement regarding the optimal procedure for patients with a BMI >50 kg/m2. This study aims to evaluate the effectiveness and safety of ring augmentation of a RYGB with a MiniMizer ring in patients with a BMI >50 kg/m2 at 2-year follow-up.
Methods: This study is a retrospective cohort study performed at the Zuyderland Medical Center in Heerlen and the Nederlandse Obesitas Kliniek Zuid. All patients with a BMI >50 kg/m2 who underwent a raRYGB with a MiniMizer ring in the period 2016-2021 are included. Total weight loss (TWL), obesity-related complications, and surgical-related complications were analyzed over 2 years post-operative.
Results: A total of 171 patients were included, of whom 78.4% were female, with a median BMI of 54.0 kg/m2 (51.4-57.7 IQR) and age of 42 (32-52 IQR) years at baseline. The mean % TWL was 15.6 at 3 months, 24.8 at 6 months, 32.1 at 1 year, and 35.2 at 2 years post-operatively. Complications of Clavien Dindo 3 or higher within the first 30 post-operative days were seen in 8 patients (4.7%) of which 1 (0.6%) was ring related.
Conclusions: The raRYGB with a MiniMizer ring in this study population results in high total weight loss results after 2 years. Ring-related complications rates are low. Therefore, we conclude that a raRYGB is an effective and safe treatment option for patients with a BMI >50 kg/m2.
Keywords: BMI over 50 kg/m2; Banded Roux-en-Y gastric bypass; Banded bypass; Banded gastric bypass; Ring-augmented gastric bypass; Severe obesity.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval: The study was presented to the medical ethics committee METC Zuyderland Zuyd who waived the need for ethical approval under Dutch law. The study has been performed in accordance with the ethical standards as stated in Dutch law. Informed Consent: A waiver for additional informed consent was obtained by the local medical ethics committee. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article.
-
Pouch Revision in Combination with Placement of a MiniMizer Ring as a Revisional Procedure in Patient with Suboptimal Clinical Response or Recurrent Weight Gain After RYGB.Obes Surg. 2025 Aug;35(8):2990-2997. doi: 10.1007/s11695-025-07984-5. Epub 2025 Jul 5. Obes Surg. 2025. PMID: 40616624 Free PMC article.
-
Efficacy and safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy versus Roux-en-Y gastric bypass in France (SADISLEEVE): results of a randomised, open-label, superiority trial at 2 years of follow-up.Lancet. 2025 Aug 23;406(10505):846-859. doi: 10.1016/S0140-6736(25)01070-0. Lancet. 2025. PMID: 40849141 Clinical Trial.
-
Addressing recurrent weight gain after Roux-en-Y gastric bypass: efficacy of a dual surgical approach-short-term results of a single-center cohort study.Surg Obes Relat Dis. 2025 Aug;21(8):863-870. doi: 10.1016/j.soard.2025.02.004. Epub 2025 Feb 18. Surg Obes Relat Dis. 2025. PMID: 40087128
-
Roux-en-Y gastric bypass versus duodenal switch in patients with body mass index ≥50 kg/m2: a systematic review and meta-analysis.Surg Obes Relat Dis. 2025 Feb;21(2):184-193. doi: 10.1016/j.soard.2024.08.042. Epub 2024 Sep 16. Surg Obes Relat Dis. 2025. PMID: 39395846
References
-
- Schwartz ML, Drew RL, Chazin-Caldie M. Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass. Obes Surg. 2004;14(9):1193–7. - PubMed
-
- Mitsakos AT, Irish W, DeMaria EJ, et al. Body mass index and risk of mortality in patients undergoing bariatric surgery. Surg Endosc. 2023;37(2):1213–21. - PubMed
-
- Maroun J, Li M, Oyefule O, et al. Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI >/= 50 kg/m(2). Surg Endosc. 2022;36(7):4946–55. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials